BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32373960)

  • 21. MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.
    Chen XF; Guo JF; Xu JF; Yin SH; Cao WL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7826-7834. PubMed ID: 31599407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-143 inhibits colorectal cancer cell proliferation by targeting MMP7.
    Yu B; Liu X; Chang H
    Minerva Med; 2017 Feb; 108(1):13-19. PubMed ID: 27827523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway.
    Wu JZ; Jiang N; Lin JM; Liu X
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2977-2985. PubMed ID: 32271415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated matrix metalloproteinase 7 expression promotes the proliferation, motility and metastasis of tongue squamous cell carcinoma.
    Yuan S; Lin LS; Gan RH; Huang L; Wu XT; Zhao Y; Su BH; Zheng D; Lu YG
    BMC Cancer; 2020 Jan; 20(1):33. PubMed ID: 31937294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA GIHCG regulates microRNA-1281 and promotes malignant progression of breast cancer.
    Fan LY; Shi KY; Xu D; Ren LP; Yang P; Zhang L; Wang F; Shao GL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10842-10850. PubMed ID: 31858553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The negative feedback loop FAM129A/CXCL14 aggravates the progression of esophageal cancer.
    Cao JW; Cui WF; Zhu HJ
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(12):4220-4227. PubMed ID: 35776020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7.
    Song N; Liu H; Ma X; Zhang S
    Cell Physiol Biochem; 2015; 37(3):1104-12. PubMed ID: 26402225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma
    Li H; Xu X; Liu Y; Li S; Zhang D; Meng X; Lu L; Li Y
    Anticancer Agents Med Chem; 2018; 18(14):2010-2016. PubMed ID: 30501604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
    Xue MY; Cao HX
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircRNA_100876 promote proliferation and metastasis of breast cancer cells through adsorbing microRNA-361-3p in a sponge form.
    Yang CY; Zhang FX; He JN; Wang SQ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6962-6970. PubMed ID: 31486496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
    Fan HT; Shi YY; Lin Y; Yang XP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Tcf-4, MMP7 and Survivin in Colorectal Cancer and Its Clinical Significance].
    Ou YR; Jing GY; Wu Q; Gao S; Cheng ZN; Dong Xiu-qin
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Jul; 46(4):554-9. PubMed ID: 26480657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PCDH10 inhibits invasion of lymphoma cells by regulating β-catenin.
    Zhang QK; Li HY; Wei XF; Feng YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4835-4841. PubMed ID: 31210316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA SNHG16 predicts poor prognosis in ESCC and promotes cell proliferation and invasion by regulating Wnt/β-catenin signaling pathway.
    Han GH; Lu KJ; Wang P; Ye J; Ye YY; Huang JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3795-3803. PubMed ID: 29949155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MIIP inhibits malignant progression of hepatocellular carcinoma through regulating AKT.
    Fang J; Chen YL; Yao HB; Peng SS; Yang P; Ding ZY
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2335-2346. PubMed ID: 32196585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.